Point72 Hong Kong’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,232
Closed -$159K 723
2022
Q3
$159K Buy
+13,232
New +$164K 0.01% 1108
2022
Q2
Sell
-3,776
Closed -$33K 2106
2022
Q1
$33K Buy
+3,776
New +$36.4K ﹤0.01% 1434
2021
Q4
Sell
-1,378
Closed -$17K 2074
2021
Q3
$17K Buy
+1,378
New +$12.7K ﹤0.01% 1721
2020
Q3
Sell
-5,357
Closed -$70K 1316
2020
Q2
$70K Buy
+5,357
New +$67.4K 0.01% 689

Other funds holding GOSS

Point72 Hong Kong's GOSS Position: Q4 2022 in Review

Point72 Hong Kong sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 13,232 shares — an estimated $159K sold.

Point72 Hong Kong first reported a position in GOSS in Q2 2020 and held it in 4 quarters. The position peaked at $159K in Q3 2022. 120 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Point72 Hong Kong reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 13,232 Gossamer Bio shares in Q4 2022, an estimated $159K.
  • Point72 Hong Kong first reported a position in Gossamer Bio in Q2 2020 and held it in 4 quarters.
  • Point72 Hong Kong's Gossamer Bio position peaked at $159K in Q3 2022.
  • 120 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.